Abstract
Objective
Thrombotic microangiopathy (TMA) has been associated with a large number of underlying diseases. We conducted a descriptive, retrospective study including all TMA adult patients admitted to our ICU, with a particular interest in infectious episodes as a trigger of TMA.
Patients
All adult patients (30) with a diagnosis of TMA admitted to the medical ICU at Saint-Louis Hospital (Paris, France) between 1992 and 1998 were retrospectively included.
Methods
All patients with clinical and microbiological evidence of bacterial infection were treated with intravenous antibiotics. The specific treatment of TMA consisted in solvent/detergent-treated plasma administration by plasma exchange or high volume plasma infusion (30 ml/kg per day) in fractionated doses.
Results
Among the 30 adult patients studied, TMA in 16 (53%) was associated with microbiologically documented infection. An acute infection was found in 8/9 patients with an HIV-related TMA, in 2/6 patients with a systemic lupus erythematosus (SLE)-related TMA and in 3/6 patients with TMA associated with other disorders. In three patients, an acute infectious disease was the only cause associated with the TMA. Four other patients had clinical manifestations suggesting an infection process but without bacteriological documentation. Escherichia coli was isolated in 7/16 cases and verotoxin was found in the stools of two other patients. All patients were treated with plasma administration and those with evidence of infection were systematically and intensively treated with antibiotics. Eventually 8 patients died (27%), 20 (67%) reached complete remission and 2 partial remission.
Conclusion
Bacterial infections are commonly observed amongst TMA patients hospitalized in ICUs and may act as a trigger of this disease. Screening for infection is a requirement in patients with TMA, either idiopathic or associated with other conditions.
Similar content being viewed by others
References
Moschowitz E (1924) Hyaline thrombosis of the terminal arterioles and capillaries: a hitherto undescribed disease. Proc N Y Pathol Soc 24:21–24
Gasser C, Gautier E, Steck A, Siebenmann RE, Oechslin R (1955) Hämolytisch-urämische syndrome: bilaterale nierenrindennekrosen bei akuten erworbenen hämolytischen anämien. Schweiz Med Wochenschr 85:905–909
Remuzzi G (1987) HUS and TTP: variable expression of a single entity. Kidney Int 32:292–308
Ruggenenti P, Remuzzi G (1998) Pathophysiology and management of thrombotic microangiopathies. J Nephrol 11:300–310
Bell WR, Braine HG, Ness PM, Kichler TS (1991) Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. N Engl J Med 325:398–403
Rock GA (2001) Management of thrombotic thrombocytopathic purpura. Br J Haematol 109:496–507
Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, Spasoff RA and the Canadian Apheresis Group (1991). Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 325:393–397
Ruggenenti P, Galbusera M, Plata Cornejo R, Bellevita P, Remuzzi G (1993) Thrombotic thrombocytopenic purpura: evidence that infusion rather than plasma exchanges induces remission of the disease. Am J Kidney Dis 21:314–318
Novitzky N, Jacobs P, Rosenstrauch W (1994) The treatment of thrombotic thrombocytopenic purpura: plasma infusion or exchange? Br J Haematol 87:317–320
Remuzzi G, Ruggenenti P (1995) The hemolytic uremic syndrome. Kidney Int 47:2–19
Moake JL (1994). Haemolytic-uraemic syndrome: basic science. Lancet 343:393–396
Boyce TG, Swerdlow DL, Griffin P (1995) Escherichia coli O157-H7 and the hemolytic uremic syndrome. N Engl J Med 333:364–368
Fakhouri F, Vincent F, Legendre C (2000) Pathological and therapeutic distinction in HUS/TTP. Lancet 355:497
Tsai H-M, Lian EC-Y (1998) Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 339:1585–1594
Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, Krause M, Scharrer V, Mittler U, Solenthaler M, Lämmle B (1998) Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 339:1578–1584
Moorthy B, Makker SP (1979) Hemolytic-uremic syndrome associated with pneumococcal sepsis. J Pediatr 95:558–559
Myers KA, Marrie TJ (1993) Thrombotic microangiopathy associated with streptococcus pneumoniae bacteremia: case report and review. Clin Infect Dis 17:1037–1040
Toscano V, Bontadini A, Falsone G, Conte R, Fois F, Fabiani A, Mariano VM, Rossi F (1995) Thrombotic thrombocytopenic purpura associated with primary tuberculosis. Infection 23:58–59
Pene F, Papo T, Brudy-Gulphe L, Cariou A, Pitte JC, Vinsonneau C (2001) Septic shock and thrombotic microangiopathy due to Mycobacterium tuberculosis in a non immunocompromised patient. Arch Intern Med 161:1347–1348
Hymes KB, Karpatkin S (1997) Human immunodeficiency virus infection and thrombotic microangiopathy. Semin Hematol 34:117–125
Marty AM, Dumler JS, Imes G, Brusman HP, Smrkovski LL, Frisman DM (1995) Ehrlichiosis mimicking thrombotic thrombocytopenic purpura. Case report and pathological correlation. Hum Pathol 26:920–925
Schröder St, Spyridopoulos I, König J, Jaschonek KG, Luft D, Seif FJ (1995) Thrombotic thrombocytopenic purpura (TTP) associated with a Borrelia burgdorferi infection. Am J Hematol 50:72–73
Riggs SA, Wray NP, Waddel CC, Rossen RD, Gyorkey F (1982) Thrombotic thrombo-cytopenic purpura complicating Legionnaires' disease. Arch Intern Med 142:2275–2280
Shalev O, Karni A, Kornberg A, Brezis M (1981) Thrombotic thrombocytopenic purpura associated with Bacteroides bacteremia. Arch Intern Med 141:692
Scarlett JD, Williamson HG, Dadson PJ, Fassett R, Peel MM (1991) A syndrome resembling thrombotic thrombocytopenic purpura associated with Capnocytophaga canimorsus septicemia. Am J Med 90:127–128
Finn M, Dale B, Isles C (1996) Beware of the dog! A syndrome resembling thrombotic thrombocytopenic purpura associated with Capnocytophaga canimorsus septicemia. Nephrol Dial Transplant 11:1839–1840
Satoh K, Takahashi H, Nagai K, Shibata A (1998) Thrombotic thrombocytopenic purpura and Herpes Zoster infection. Ann Intern Med 108:154–155
Jeejeebhoy FM, Zaltzman JS (1998) Thrombotic microangiopathy in association with cytomegalovirus infection in a renal transplant patient. Transplantation 65:1645–1648
Wasserstein A, Hill G, Goldfarb S, Goldberg M (1981) Recurrent thrombotic thrombocytopenic purpura after viral infection. Arch Intern Med 141:685–687
Miniero R, Nesi F, Vai S (1997) Cryptococcal meningitis following a thrombotic microangiopathy in an unrelated donor bone marrow transplant recipient. Pediat Hematol Oncol 14:469–474
Creager AJ, Brecher ME, Bandarenko N (1998) Thrombotic thrombocytopenic purpura that is refractory to therapeutic plasma exchange in two patients with occult infection. Transfusion 38:419–423
Le Gall JR, Lemeshow S, Saulnier F (1993) A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957–2963
Le Gall JR, Klar J, Lemeshow S, Saulnier F, Alberti C, Artigas A, Teres D for the ICU scoring group (1996) The logistic organ dysfunction system. A new way to assess organ dysfunction in the intensive care unit. JAMA 276:802–810
Coppo P, Bussel A, Charrier S, Adrie C, Galicier L, Boulanger E, Veyrandier A, Leblanc T, Alberti C, Azoulay E, Le Gall JR, Schlemmer B (2003) High dose plasma infusion versus plasma exchange as early treatment of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome. Medicine 82:27–38
Patton JF, KR Manning, D Case, J Owen (1994) Serum lactate deshydrogenase and platelet count predict survival in thrombotic thrombocytopenic purpura. Am J Hematol 47:94–99
Light BR (1992) Sepsis syndrome. In: Hall JB, Schmidt GA, Wood LD (eds) Principles of critical care. McGraw-Hill, New York, pp 645–655
Obrig TG, Del Vecchio PJ, Brown JE, Moran TP, Rowland BM, Judge TK, Rothman SW (1988) Direct cytotoxic action of Shiga toxin on human vascular endothelial cells. Infect Immun 56:2373–2378
Keusch GT, Acheson DWK (1997) Thrombotic thrombocytopenic purpura associated with Shiga toxins. Semin Hematol 34:106–116
Laurence J, Mitra D, Steiner M, Staiano-Coico L, Jaffe E (1996) Plasma from patients with idiopathic and human immunodeficiency virus-associated thrombotic thrombocytopenic purpura induces apoptosis in microvascular endothelial cells. Blood 87:3245–3246
Tannahill CL, Fukuzuka K, Marum T, Abouhamze Z, MacKay SL, Copeland EM 3rd, Moldawer LL (1999) Discordant tumor necrosis factor-alpha superfamily gene expression in bacterial and endotoxemic shock. Surgery 126:349–357
Noris M, Ruggenenti P, Pena A, Orisio S, Caprioli J, Skerka C, Vasile B, Zipfel PF, Remuzzi G (1999) Hypocomplementemia discloses predisposition to hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: role of factor H abnormalities. J Am Soc Nephrol 10:281–293
Wong CS, Jelacic SJ, Habeeb RL, Watkins SL, Tarr PI (2000) The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med 342:1930–1936
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Coppo, P., Adrie, C., Azoulay, E. et al. Infectious diseases as a trigger in thrombotic microangiopathies in intensive care unit (ICU) patients?. Intensive Care Med 29, 564–569 (2003). https://doi.org/10.1007/s00134-003-1676-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-003-1676-4